The first International Meeting on Pulmonary Rare Diseases and Orphan Drugs was held in 2005; since then, the Meeting has taken place regularly every 2 years, with growing success and ever increasing numbers of participants and speakers from around the world.
The International Meeting on Pulmonary Rare Diseases and Orphan Drugs, this year endorsed by the European respiratory Society, is the only European event dedicated to different types of rare pulmonary diseases affecting both parenchymal and vascular structures. In recent years, the interest for rare diseases has grown throughout the entire medical community, and many respiratory physicians were pioneers in this field of medicine.
The 8th International Meeting on Pulmonary Rare Diseases and Orphan Drugs goes further in this direction, highlighting that rare diseases represent an important field of medicine not only for pulmonologists who are skilled in diagnosing and treating particular groups of these illnesses but for all respiratory physicians.
Knowledge exchange and dissemination among experts on different areas of clinical and basic research in respiratory medicine, with different specialized pulmonary medicine expertise (from vascular to interstitial lung diseases), is part of the stimulating challenge of providing new insights into science and clinical care, thus helping patients and supporting doctors.
Special thank the whole faculty, the sponsors and the participants for their support and enthusiasm.
Presidents of the Congress
Sergio Harari and Marc Humbert
Deadline pour les abstracts le 4 janvier 2019
